BUZZ-Eli Lilly, US-listed Novo Nordisk fall; Trump says weight-loss drug prices would be lowered
Reuters
Oct 17
BUZZ-Eli Lilly, US-listed <a href="https://laohu8.com/S/NVO">Novo Nordisk</a> fall; Trump says weight-loss drug prices would be lowered
** Shares of weight-loss drug developers Eli Lilly LLY.N and U.S.-listed shares of Novo Nordisk NOVOb.CO fall between 1% and 3% in extended trading
** Lilly down 1.3% at $811.50, Novo falls 3.6% to $54.10
** U.S. President Donald Trump says that prices of weight-loss drugs, such as Novo's Ozempic, would be lowered
** "They'll be much lower," Trump told reporters during an event in the Oval Office
** Up to last close, LLY up 6.1% and U.S.-listed Novo down 34.8% YTD
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.